Log in

Relevant bibliographies by topics / Multiple drug resistant tb / Books

To see the other types of publications on this topic, follow the link: Multiple drug resistant tb.

Books on the topic 'Multiple drug resistant tb'

Author: Grafiati

Published: 4 June 2021

Last updated: 18 February 2022

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 26 books for your research on the topic 'Multiple drug resistant tb.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse books on a wide variety of disciplines and organise your bibliography correctly.

1

Border, Peter. Diseases fighting back: The growing resistance of TB and other bacterial diseases to treatment. Parliamentary Office of Science and Technology, 1994.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

2

Gillespie, Stephen H., ed. Management of Multiple Drug-Resistant Infections. Humana Press, 2004. http://dx.doi.org/10.1007/978-1-59259-738-3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Hopkins, Tanne Janice, ed. Timebomb: The global epidemic of multi-drug-resistant tuberculosis. McGraw-Hill, 2002.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

4

Wiegandt, Axel. Framework to address multi-drug-resistant TB in the Pacific island countries and territories. Secretariat of the Pacific community, 2010.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

5

author, Wilker Ian, and Ambrose Marylou author, eds. Tuberculosis and superbugs: Examining TB and bacterial infections. Jasmine Health, 2014.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

6

Nurses, International Council of. TB guidelines: For nurses in the care and control of tuberculosis and multi-drug resistant tuberculosis. International Council of Nurses, 2004.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

7

Vinšová, Jarmila. Development of new MDR-tuberculosis drugs. Nova Science Publisher, 2010.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

8

World Health Organization (WHO). Management of MDR-TB: A field guide, a companion document to Guidelines for the programmatic management of drug-resistant tuberculosis. World Health Organization, 2009.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

9

Institute of Medicine (U.S.). Forum on Drug Discovery, Development, and Translation, ed. Addressing the threat of drug-resistant tuberculosis: A realistic assessment of the challenge : workshop summary. National Academies Press, 2009.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

10

Parliamentary Office of Science and Technology. Diseases fighting back. Parliamentary Office of Science and Technology, 1994.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

11

The global threat of drug-resistant TB: A call to action for World TB Day : briefing and hearing before the Subcommittee on Africa and Global Health of the Committee on Foreign Affairs, House of Representatives, One Hundred Tenth Congress, first session, March 21, 2007. U.S. G.P.O., 2007.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

12

File, Thomas. New insights in the treatment of severe infections in the multiple-drug resistant situation: Proceedings of a satellite symposium to the 11th International Congress on Infectious Diseases, Cancun, Mexico, March 5, 2004. Karger, 2004.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

13

Emami, Saeed. New quinolones with potential anti-MRSA activity. Nova Science, 2009.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

14

F, Amábile-Cuevas Carlos, ed. Multiple drug resistant bacteria. Horizon Scientific Press, 2003.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

15

(Editor), Carlos F. Amabile-Cuevas, and Carlos F. Amabile Cuevas (Editor), eds. Multiple Drug Resistant Bacteria. Taylor & Francis, 2009.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

16

H, Gillespie S., ed. Management of multiple drug-resistant infections. Humana Press, 2004.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

17

Gillespie, Stephen H. Management of Multiple Drug-resistant Infections. Humana Press Inc.,U.S., 2004.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

18

Gillespie, Stephen H. Management of Multiple Drug-Resistant Infections (Infectious Disease). Humana Press, 2004.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

19

Stefan H. E. Kaufmann (Editor) and H. Hahn (Editor), eds. Mycobacteria and Tb (Issues in Infectious Diseases, 2). S. Karger Publishers (USA), 2002.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

20

WHO Regional Office for Europe Staff. Roadmap to Prevent and Combat Drug-Resistant Tuberculosis: The Consolidated Action Plan to Prevent and Combat Multidrug- And Extensively Drug-Resistant Tuberculosis in the WHO European Region, 2011-2015. World Health Organization, 2012.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

21

File, T. M. Jr. New Insights in the Treatment of Severe Infections in the Multiple-Drug Resistant Situation: Satellite Symposium to the 11th International Congress on ... March 2004: Proceedings (Chemotherapy). Not Avail, 2004.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

22

Al-Darraji, Haider A., and Frederick L. Altice. The Perfect Storm. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199374847.003.0008.

Full text

Abstract:

Globally, tuberculosis (TB) is a major cause of morbidity and mortality among people who use drugs (PWUD), particularly those co-infected with HIV. This chapter describes how TB is prevalent in several prison systems by virtue of the concentration of PWUD and people living with HIV. TB is further amplified within this system through overcrowding, poor ventilation, and delayed access to quality prevention and treatment services. In many countries, individuals cycling through prisons are inadequately screened and treated for TB, and affected individuals may have frequent treatment interruptions.

APA, Harvard, Vancouver, ISO, and other styles

23

Tuberculosis in the Americas. 2019 Regional Report. Organización Panamericana de la Salud, 2020. http://dx.doi.org/10.37774/9789275122730.

Full text

Abstract:

Tuberculosis is one of the ten leading causes of death worldwide, and still represents a major public health problem in the Region of the Americas. The Region has made great strides in TB prevention and control; nevertheless, at the current rate of decline in the number of TB deaths and incidence of TB, the proposed targets and milestones needed to end TB will not be achieved. Countries must thus ramp up their efforts to meet these targets. Tuberculosis in the Americas: Regional Report presents the situation of tuberculosis in the Region, as well as the progress made by countries in the preven

APA, Harvard, Vancouver, ISO, and other styles

24

Directrices unificadas de la OMS sobre el tratamiento de la tuberculosis farmacorresistente. Organización Panamericana de la Salud, 2020. http://dx.doi.org/10.37774/9789275321867.

Full text

Abstract:

Estas directrices unificadas se han actualizado con arreglo a los procesos del grupo de elaboración de las directrices que se llevaron a cabo entre el 2011 y el 2018 de conformidad con los requisitos de la OMS. Este documento sustituye a otras recomendaciones de la OMS relativas al tratamiento de la tuberculosis (TB) multirresistente y resistente a la rifampicina (TB-MDR/RR) publicadas desde el 201. En este documento se incluyen las preguntas sobre población, intervención, comparador y resultado (PICO, por su sigla en inglés) subyacentes a las recomendaciones y la posología revisada de los med

APA, Harvard, Vancouver, ISO, and other styles

25

Paterson, David L., and Yoshiro Hayashi. Antimicrobial selection policies in the ICU. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780199600830.003.0286.

Full text

Abstract:

Antibiotic selection is a crucial drug choice in critically-ill patients. Optimization of empiric antibiotic choice can be gained by knowledge of the site of infection and the probable causative organisms at that site. This should be linked with knowledge of the local epidemiology of antibiotic resistance in the actual intensive care unit housing the patient. Initial empiric antimicrobial choice may need to be broad in order to cover potential antibiotic-resistant pathogens. However, it is important to be prudent in antibiotic strategy since the selection of multiple-resistant organisms by exc

APA, Harvard, Vancouver, ISO, and other styles

26

Walker, Matthew C., and Robin S. B. Williams. Identifying the Molecular Mechanism of the Medium Chain Triglyceride (Ketogenic) Diet. Edited by Dominic P. D’Agostino. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780190497996.003.0033.

Full text

Abstract:

The medium chain triglyceride (MCT) ketogenic diet provides a highly effective and commonly used approach for treating drug-resistant epilepsy. It is associated with elevated levels of two MCT-derived fatty acids, decanoioc and octanoic acids. Researchers have identified a role for decanoic acid and a range of novel related chemicals in seizure control in multiple acute in vitro and in vivo models. A principal mechanism of decanoic acid is direct inhibition of AMPA receptors, key excitatory neurotransmitter receptors widely recognized as a target for seizure control. These data suggest a thera

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!